Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Crexendo (CXDO) EBT (2016 - 2026)

Crexendo filings provide 15 years of EBT readings, the most recent being $1.4 million for Q4 2025.

  • On a quarterly basis, EBT rose 123.42% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.4 million, a 184.33% increase, with the full-year FY2025 number at $5.4 million, up 184.33% from a year prior.
  • EBT hit $1.4 million in Q4 2025 for Crexendo, down from $1.5 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.7 million in Q3 2023 to a low of -$33.0 million in Q4 2022.
  • Median EBT over the past 5 years was $136000.0 (2023), compared with a mean of -$1.5 million.
  • Biggest five-year swings in EBT: tumbled 6166.67% in 2022 and later skyrocketed 693.59% in 2024.
  • Crexendo's EBT stood at $820000.0 in 2021, then tumbled by 4130.24% to -$33.0 million in 2022, then surged by 100.24% to $78000.0 in 2023, then skyrocketed by 693.59% to $619000.0 in 2024, then skyrocketed by 123.42% to $1.4 million in 2025.
  • The last three reported values for EBT were $1.4 million (Q4 2025), $1.5 million (Q3 2025), and $1.3 million (Q2 2025) per Business Quant data.